Investment Banking Analyst - Life Sciences M&A

Blacklock is representing a top-tier investment bank in the search for an Investment Banking Analyst to join its Life Sciences Mergers & Acquisitions team in New York.

The Analyst will work closely with senior bankers on the execution of M&A transactions and strategic advisory assignments for leading biotechnology, pharmaceutical, medical device, diagnostics, and healthcare services companies. This position offers hands-on transaction experience, meaningful client exposure, and deep specialization within the life sciences sector.

• Support the execution of buy-side and sell-side M&A transactions, strategic alternatives, and related advisory assignments
• Build and maintain detailed financial models, including DCF analyses, comparable companies, precedent transactions, and merger models
• Prepare marketing and execution materials such as pitch books, confidential information memoranda, and management presentations
• Conduct in-depth company, industry, and scientific research across life sciences subsectors
• Analyze financial statements, operating metrics, pipelines, and valuation drivers specific to life sciences businesses
• Assist with due diligence coordination, data room management, and interaction with legal, accounting, and other advisors
• Work closely with Associates, Vice Presidents, and senior team members in a fast-paced, collaborative environment

• Bachelor’s degree with strong academic credentials
• 1–3 years of investment banking experience, or relevant experience in consulting, equity research, or corporate finance (life sciences exposure preferred)
• Strong financial modeling, valuation, and analytical skills
• Demonstrated interest in life sciences, healthcare, biotechnology, or pharmaceuticals
• Exceptional attention to detail and ability to manage multiple priorities under tight deadlines
• Strong written and verbal communication skills
• High level of professionalism, work ethic, and ownership mentality